Immunic (IMUX) Minority Interest (2013 - 2020)

Immunic (IMUX) posted Minority Interest of $103.3 million for Q1 2014, up 7504.78% sequentially from $1.4 million in Q4 2013.

Analysis

Immunic (IMUX) Minority Interest (2013 - 2020) Analysis & Trends

Immunic has reported Minority Interest for 2 years, with the latest figure at $103.3 million in Q1 2014.

Quarterly Minority Interest changed N/A year-over-year to $103.3 million in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $103.3 million (changed N/A YoY) and the FY2013 annual result came in at $1.4 million, changed N/A from the prior year.
Minority Interest climbed to $103.3 million in Q1 2014 per IMUX's latest filing, from $1.4 million in the prior quarter.
Over five years, Minority Interest peaked at $103.3 million in Q1 2014 and troughed at $1.4 million in Q4 2013.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
10	Immunic	546.30 Mn	546.30 Mn	-

Historic Data

Download Data